SCHEMBL4717754

SCHEMBL4717754

Nc1cc2c[c]ccc2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.54
EHMT2 Q96KQ7 1/20 0.38
CYP2A6 P11509 1/20 0.31
KEAP1 Q14145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4467591 0.74
SCHEMBL2452605 0.74 DAO (0.31)
SCHEMBL4460967 0.74 F11 (0.31)
SCHEMBL445877 0.74 CYP2A6 (0.48) CYP2A6KEAP1
SCHEMBL1202420 0.71 FLT3 (0.42)
SCHEMBL37667 0.70 AOC3 (1.00) AOC3EHMT2CYP2A6
SCHEMBL29363162 0.70 AOC3 (1.00) AOC3EHMT2CYP2A6
SCHEMBL8205395 0.69 CYP2A6 (0.58) CYP2A6
SCHEMBL1465757 0.69 SYK (0.32)
SCHEMBL2562389 0.69 RHEB (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216230-B1 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC (US) 2008-04-23 EP disclosed